Weaver Consulting Group Bristol Myers Squibb CO Transaction History

Weaver Consulting Group

$287 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $9,596 - $10,880	200 Added 4.51%	4,632 $251,000
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $7,175 - $8,561	-148 Reduced 3.23%	4,432 $227,000
Q3 2023 Oct 13, 2023	SELL	$57.89 - $64.73 $7,236 - $8,091	-125 Reduced 2.66%	4,580 $265,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $445 - $495	-7 Reduced 0.15%	4,705 $300,000
Q1 2023 Apr 11, 2023	SELL	$65.71 - $74.53 $14,916 - $16,918	-227 Reduced 4.6%	4,712 $326,000
Q4 2022 Jan 09, 2023	SELL	$68.48 - $81.09 $43,484 - $51,492	-635 Reduced 11.39%	4,939 $0
Q3 2022 Oct 04, 2022	SELL	$0.13 - $76.84 $0 - $230	-3 Reduced 0.05%	5,574 $396,000
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $34,857 - $38,390	-480 Reduced 7.92%	5,577 $429,000
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $18,609 - $21,694	-347 Reduced 5.42%	6,057 $378,000
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $15,620 - $18,297	264 Added 4.3%	6,404 $379,000
Q2 2021 Jul 06, 2021	BUY	$61.91 - $67.42 $49,528 - $53,936	800 Added 14.98%	6,140 $410,000
Q1 2021 Apr 07, 2021	SELL	$59.34 - $66.74 $11,927 - $13,414	-201 Reduced 3.63%	5,340 $337,000
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $10,855 - $12,300	-188 Reduced 3.28%	5,541 $344,000
Q3 2020 Oct 28, 2020	SELL	$57.43 - $63.64 $16,022 - $17,755	-279 Reduced 4.64%	5,729 $345,000
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $4,732 - $6,877	102 Added 1.73%	6,008 $335,000
Q3 2019 Nov 22, 2019	BUY	$42.77 - $50.71 $8,554 - $10,142	200 Added 3.51%	5,906 $263,000
Q1 2019 Jun 19, 2019	BUY	$45.12 - $53.8 $257,454 - $306,982	5,706 New	5,706 $263,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.

Account